Drug Shortage Report for MYLAN-RISPERIDONE ODT
Report ID | 206 |
Drug Identification Number | 02413493 |
Brand name | MYLAN-RISPERIDONE ODT |
Common or Proper name | RISPERIDONE ODT |
Company Name | MYLAN PHARMACEUTICALS ULC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | RISPERIDONE |
Strength(s) | 1MG |
Dosage form(s) | TABLET (ORALLY DISINTEGRATING) |
Route of administration | ORAL |
Packaging size | 100BT |
ATC code | N05AX |
ATC description | ANTIPSYCHOTICS |
Reason for shortage | Requirements related to complying with good manufacturing practices. |
Anticipated start date | |
Actual start date | 2017-01-23 |
Estimated end date | Unknown |
Actual end date | 2021-11-15 |
Shortage status | Resolved |
Updated date | 2021-11-23 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.